US · Health Claims
Health Claims regulations in US
RegSig maps health claims regulatory intelligence in US to your product portfolio—so compliance teams can proactively manage exposure across authorities, documents, and time horizons.
- 4 representative signals
- 3 authorities
- Usage-based registration
US
Country
Health Claims
Topic
3
Represented authorities
4
Signals shown
Key Health Claims signals for US
Compliance Enforcement on Health Claims Requirements for Compliance Remediation
Near-termWhat changed: Front-of-pack and benefit-forwarding display expectations shifted in circulated or final text, constraining how nutrition-related benefits may be highlighted relative to base label disclosures.
FDA Proposed Shift on Health Claims Requirements for FDA-regulated Labels
Near-termWhat changed: Front-of-pack and benefit-forwarding display expectations shifted in circulated or final text, constraining how nutrition-related benefits may be highlighted relative to base label disclosures.
FDA Guidance Proposal on Health Claims Requirements for Us Market Labels
Near-termWhat changed: Federal regulatory text on this topic was revised, updating labeling, claims, or compliance documentation expectations on affected products.
State Guidance Shift on Health Claims Requirements for State Labeling Programs
Horizon TBDWhat changed: Front-of-pack and benefit-forwarding display expectations shifted in circulated or final text, constraining how nutrition-related benefits may be highlighted relative to base label disclosures.
Full signal detail, recommended actions, and portfolio exposure mapping are available after registration.
Authorities referenced in these signals
Explore more topics: Browse Health Claims →
Individual access
Monitor Health Claims · US signals in your portfolio
RegSig maps global regulatory signals directly to your product portfolio. Independent practitioners can get started with usage-based billing—pay only for what you run.
